MICL/CLEC12A Antibody (812303) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2950JF669
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 669
Antibody Source
Monoclonal Rat IgG2A Clone # 812303
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse MICL/CLEC12A with an N-terminal 9-His tag
Thr67-Arg267
Accession # Q504P2
Thr67-Arg267
Accession # Q504P2
Specificity
Detects mouse MICL/CLEC12A in direct ELISAs.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2A
Applications for MICL/CLEC12A Antibody (812303) [Janelia Fluor® 669]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: MICL/CLEC12A
Long Name
Myeloid Inhibitory C-type Lectin-like Receptor
Alternate Names
CD371, CLEC12A, CLL-1, DCAL-2
Additional MICL/CLEC12A Products
Product Documents for MICL/CLEC12A Antibody (812303) [Janelia Fluor® 669]
Product Specific Notices for MICL/CLEC12A Antibody (812303) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...